Report Id: PODM0721
Ophthalmic Drugs Market Size by Drug Class (Anti-glaucoma Drug, Dry eye Drug, Ophthalmic Anti-allergy/Inflammatory, Retinal Drug, Anti-infective Drugs, Other Drugs), By Product Type (OTC Drug, Prescription Drug, Residential), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
The Ophthalmic Drugs Market is expected to be around US$ 61.50 Billion by 2028 at a CAGR of 6.78% in the given forecast period.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- Alcon
- Bausch Health
- Johnson & Johnson Services Inc
- Allergan
- Pfizer Inc.
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
6
REPORT DESCRIPTION
The Ophthalmic Drugs Market is expected to be around US$ 61.50 Billion by 2028 at a CAGR of 6.78% in the given forecast period.
The ophthalmic drugs are the formulations that are planned for the treatment of eye diseases such as diabetic macular edema, cytomegalovirus retinitis, cataract, glaucoma, colour blindness, and age-related macular degeneration. Growth in geriatric population; growth in prevalence of eye disease such as cataract, glaucoma, and macular degeneration; surge in demand of ophthalmic drug, and growth in investment in R&D activities by many healthcare companies are the key factors that drive the development of the global ophthalmic drugs market. Moreover, surge in demand for ophthalmic drugs, growth in alertness about healthcare to prevent the risk of eye diseases, and initiatives taken by government for development & manufacturing of different mixture of ophthalmic drugs propel the development of the market. Nevertheless, prolonged time period for manufacturing and formulating the ophthalmic drug as well as side effects associated with the ophthalmic drugs are expected to restrict the market development during the forecast period. Growing alertness about eye-related diseases and increasing advancements in technologies are some of the major factors expected to accelerate market development.
The global Ophthalmic Drugs market is segregated on the basis of Drug Class as Anti-glaucoma Drug, Dry eye Drug, Ophthalmic Anti-allergy/Inflammatory, Retinal Drug, Anti-infective Drugs, and Other Drugs. Based on Product Type the global OPHTHALMIC DRUGS market is segmented in OTC Drug, Prescription Drug, and Residential.
The global Ophthalmic Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The OPHTHALMIC DRUGS market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Alcon, Johnson & Johnson Services, Inc., Bausch Health, Allergan, Pfizer, Inc., Bayer AG, Santen Pharmaceutical Co. Ltd., Genentech, Inc., Novartis AG, Regeneron, and others are among the major players in the global OPHTHALMIC DRUGS market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Ophthalmic Drugs Market has been segmented as below:
Ophthalmic Drugs Market, By Drug Class
- Anti-glaucoma Drug
- Dry eye Drug
- Ophthalmic Anti-allergy/Inflammatory
- Retinal Drug
- Anti-infective Drugs
- Other Drugs
Ophthalmic Drugs Market, By Product Type
- OTC Drug
- Prescription Drug
Ophthalmic Drugs Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Ophthalmic Drugs Market, By Company
- Alcon
- Johnson & Johnson Services, Inc.
- Bausch Health
- Allergan
- Pfizer, Inc.
- Bayer AG
- Santen Pharmaceutical Co. Ltd.
- Genentech, Inc.
- Novartis AG
- Regeneron
The report covers:
- Global Ophthalmic Drugs market sizes from 2021 to 2028, along with CAGR for 2023-2028
- Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
- Global Ophthalmic Drugs market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Ophthalmic Drugs market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
Report Scope:
The global Ophthalmic Drugs market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Ophthalmic Drugs market share. Major industry players with significant revenue share include Alcon, Johnson & Johnson Services, Inc., Bausch Health, Allergan, Pfizer, Inc., Bayer AG, Santen Pharmaceutical Co. Ltd., Genentech, Inc., Novartis AG, Regeneron, and others.
Reasons to Buy this Report:
- Gain detailed insights on the Ophthalmic Drugs industry trends
- Find complete analysis on the market status
- Identify the Ophthalmic Drugs market opportunities and growth segments
- Analyse competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Nonalcoholic Steatohepatitis market
Protein Purification & Isolation Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Ophthalmic Drugs Market, By Drug Class
5.1. Key Points
5.2. Anti-glaucoma Drug
5.3. Dry eye Drug
5.4. Ophthalmic Anti-allergy/Inflammatory
5.5. Retinal Drug
5.6. Anti-infective Drugs
5.7. Other Drugs
6. Ophthalmic Drugs Market, By Product Type
6.1. Key Points
6.2. OTC Drug
6.3. Prescription Drug
6.4. Residential
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profiles
8.1 Alcon
8.1.1 Company Overview
8.1.2 Product/Service Landscape
8.1.3 Financial Overview
8.1.4 Recent Developments
8.2 Johnson & Johnson Services, Inc.
8.2.1 Company Overview
8.2.2 Product/Service Landscape
8.2.3 Financial Overview
8.2.4 Recent Developments
8.3 Bausch Health
8.3.1 Company Overview
8.3.2 Product/Service Landscape
8.3.3 Financial Overview
8.3.4 Recent Developments
8.4 Allergan
8.4.1 Company Overview
8.4.2 Product/Service Landscape
8.4.3 Financial Overview
8.4.4 Recent Developments
8.5 Pfizer, Inc.
8.5.1 Company Overview
8.5.2 Product/Service Landscape
8.5.3 Financial Overview
8.5.4 Recent Developments
8.6 Bayer AG
8.6.1 Company Overview
8.6.2 Product/Service Landscape
8.6.3 Financial Overview
8.6.4 Recent Developments
8.7 Santen Pharmaceutical Co. Ltd.
8.7.1 Company Overview
8.7.2 Product/Service Landscape
8.7.3 Financial Overview
8.7.4 Recent Developments
8.8 Genentech, Inc.
8.8.1 Company Overview
8.8.2 Product/Service Landscape
8.8.3 Financial Overview
8.8.4 Recent Developments
8.9 Novartis AG
8.9.1 Company Overview
8.9.2 Product/Service Landscape
8.9.3 Financial Overview
8.9.4 Recent Developments
8.10 Regeneron
8.10.1 Company Overview
8.10.2 Product/Service Landscape
8.10.3 Financial Overview
8.10.4 Recent Developments
The Ophthalmic Drugs Market has been segmented as below:
Ophthalmic Drugs Market, By Drug Class
- Anti-glaucoma Drug
- Dry eye Drug
- Ophthalmic Anti-allergy/Inflammatory
- Retinal Drug
- Anti-infective Drugs
- Other Drugs
Ophthalmic Drugs Market, By Product Type
- OTC Drug
- Prescription Drug
Ophthalmic Drugs Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Ophthalmic Drugs Market, By Company
- Alcon
- Johnson & Johnson Services, Inc.
- Bausch Health
- Allergan
- Pfizer, Inc.
- Bayer AG
- Santen Pharmaceutical Co. Ltd.
- Genentech, Inc.
- Novartis AG
- Regeneron
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of Ophthalmic Drugs Market?
The market is expected to grow at a CAGR of 6.78% during the study period (2023-2028)
How big is the Ophthalmic Drugs Market value?
The Ophthalmic Drugs Market is expected to be around US$ 61.50 Billion by 2028
What is the segment’s covered for the Ophthalmic Drugs Market?
The segment included in Ophthalmic Drugs Market is Drug Class, Product Type, Company and region.
Who are the major key vendors in Ophthalmic Drugs Market?
Some key players operating in the Ophthalmic Drugs Market include Alcon, Johnson & Johnson Services, Inc., Bausch Health, Allergan, Pfizer, Inc., Bayer AG, Santen Pharmaceutical Co. Ltd., Genentech, Inc., Novartis AG
what are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE